Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Celadon Pharmaceuticals PLC has inked a significant five-year sales contract valued up to £10.5 million for its UK-produced medicinal cannabis with a new healthcare company, bolstering its potential order book to approximately £40.7 million. This deal complements an earlier strategic collaboration with Valeos Pharma A/S, enhancing Celadon’s European market supply capabilities and marking a key step in meeting the surging demand for pharmaceutical-grade medicinal cannabis.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.
